Clinical Trial Update: Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing different induction-dose approaches of regorafenib in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED